Nerve Transfer to Improve Function in High Level Tetraplegia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorWashington University School of Medicine

About this trial

The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury.

Participants will:

* undergo standard of care pre- and post-op testing and study exams * complete pre- and post-questionnaires * undergo standard of care nerve transfer surgeries * follow-up with surgeon at 6/12/18/24/36 and potentially at 48 months * attend therapy at local therapist for up to 2 years postop.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18-80 years of age

High cervical SCI (motor level C1-C4)

Motor complete SCI AIS grade A-B

Plateaued spontaneous recovery for at least 6 months of non-operative therapy

Disqualifiers

Active infection at the operative site or systemic infection

Any return or ongoing recovery of distal motor function

Significant joint contractures and/or limitations in passive range of motion in the arm

Mentally or physically compromised making it impossible to complete study activities

Trial population

Patients with high-level SCI injury (C1-C4) with complete lack of upper extremity function. Occurrence of injury should be greater than 6 months but fewer than 60 months

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Elbow Dynamometry

Change from baseline to 36-48 months post-surgery. Elbow dynamometer measures muscle strength using a handheld portable dynamometer

Time frame
36-48 months post-surgery
2

Spinal Cord Independence Measure

Change from baseline to 36-48 months post-surgery. SCIM addresses three specific areas of function in patients with SCI, 1) Self-care (feeding, grooming, bathing, and dressing), 2) respiration and sphincter management, and 3) patient's mobility abilities (transfers from bed and indoors/outdoors). SCIM guide clinicians in determining treatment goals/objectives for SCI patients helping therapists assess measurable outcomes in their functional independence. Scores range from 0-100 with a higher score representing better function.

Time frame
36-48 months post-surgery
3

Motor strength in medical research council grade (MRC)

Change in baseline to 36-48 Months post-surgery. The manual muscle testing is a reliable measure of motor strength when assessed by a trained examiner. Scores range from 0-5, with the highest number representing a better score.

Time frame
36-48 months post-surgery
4

Electrodiagnosis (Nerve Conduction Study and Electromyography

Change in baseline to 36-48 Months post-surgery. NCS/EMG evaluate neuromuscular health and inform the integrity of lower motor neurons.

Time frame
36-48 months post-surgery

Secondary outcomes

1

Canadian Outcomes Performance Measure (COPM)

Change from baseline to 36-48 months post-surgery. COPM is a validated outcome measure for SCI patients focusing on occupational performance in all areas of life. Scores range from 5-50 for performance and satisfaction. The higher scores reflect better performance and satisfaction.

Time frame
36-48 Months post-surgery
2

Capabilities of Upper Extremity Questionnaire (CUE-Q)

Change from baseline to 36-48 months post-surgery. CUE-Q detects changes in upper extremity function. Scores range from 32-224 with higher scores reflecting better function.

Time frame
36-48 Months post-surgery
3

Modified Ashworth Scale (MAS)

Change from baseline to 36-48 months post-surgery. MAS is a reliable measure for rating spasticity in SCI. Scores range from 0-32 with higher scores reflecting better function.

Time frame
36-48 Months post-surgery
4

Spinal Cord Injury Quality of LIfe Questionnaire

Change from baseline to 36-48 months post-surgery. SCI-QOL is designed to measure subjective quality of life in terms of satisfaction and importance. Range of scores is 0 to 30 with the higher scores reflecting a better quality of life..

Time frame
36-48 Months post-surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington University School of Medicine

Lead sponsor

University of Michigan

Collaborator

The Methodist Hospital Research Institute

Collaborator

University of Pennsylvania

Collaborator

University of Utah

Collaborator

Stanford University

Collaborator

University of Miami

Collaborator

Johns Hopkins University

Collaborator

University of Alberta

Collaborator

Wake Forest University Health Sciences

Collaborator

Congressionally Directed Medical Research Programs

Collaborator